A full-day, in-person, evidence-based urology education meeting designed to enhance GP confidence in the assessment, investigation, management and referral of common urological conditions. The program provides practical guidance aligned with current Australian guidelines and local referral pathways, with a focus on youth and older adult populations.
Join Western Health and NWMPHN at the UROWEST II 2026 a specialist-led educational meeting developed to support general practitioners in delivering high-quality, evidence-based urological care in the community. The program covers common and high-impact clinical presentations including benign prostatic hyperplasia (BPH), erectile dysfunction, haematuria, urinary incontinence, kidney stones, urethral stricture disease, prostate cancer, kidney lesions and testicular cancer.
Sessions emphasise practical clinical decision-making, including appropriate investigation strategies, PSA interpretation, MRI and PSMA PET in prostate cancer, oncology referral criteria, active surveillance and shared-care models. Participants will gain clarity on when to manage in primary care and when to refer, as well as how to coordinate post-operative and survivorship care.
Case-based discussion will integrate priority populations, including youth (testicular cancer recognition and communication) and older adults (frailty, polypharmacy, continence, cancer survivorship and community-based management). Local referral pathways and HealthPathways Melbourne will be embedded to ensure participants can apply learning immediately in practice.
The meeting is structured to translate specialist knowledge into practical skills that improve early cancer detection, optimise chronic urological disease management, and strengthen collaboration between primary and specialist care.
Learning outcomes:
- Identify and risk-stratify red flag urological symptoms that require urgent investigation or specialist referral.
- Interpret and apply evidence-based use of PSA testing, imaging (including MRI and PSMA PET), urinalysis and metabolic investigations in primary care.
- Initiate and optimise first-line management for LUTS, erectile dysfunction, urinary incontinence and kidney stones, particularly in older adults with multimorbidity.
- Implement appropriate referral pathways and shared-care models for patients with prostate, kidney and testicular cancer, including post-treatment community management.
Please see registration for list of speakers
All attendee to the event will be eligible for the concessional parking rate of $7.20
